CClinicalTrials.gg
TerminatedNCT04764929Updated Jul 29, 2024Results posted

Pediatric Helmet CPAP Pilot Study

An interventional study of Helmet CPAP in Bronchiolitis, Viral, Pneumonia, Viral and Pneumonia, Bacterial, sponsored by Columbia University. Terminated at 1 site in United States. Open to participants aged 1 Month to 5 Years. Per ClinicalTrials.gov, last updated 2024-07-29.

Sponsored by Columbia University · Not applicable, Interventional, and Treatment

Why this study was terminated
Investigators left the institution
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
1 Month to 5 Years
Sex
All
01

Study summary

This a research study to find out whether giving Continuous Positive Airway Pressure (CPAP) through a Helmet is the same or better than giving CPAP through a Facemask, Nasal Mask, or Nasal Prongs. CPAP can help kids with lung infections breathe easier. The machine delivers pressurized air, which may help people with lung infections breathe more easily. Doctors routinely use a Facemask, Nasal Mask or Nasal Prongs to give CPAP for kids with lung infections, but the researchers want to know whether using Helmet CPAP is the same or better.

Read the detailed description

Prior clinical trials have demonstrated efficacy of Helmet CPAP in adults with acute respiratory distress syndrome, superior tolerance and improved respiratory scores compared to nasal/facial CPAP in infants, and no major safety concerns were identified with the use of helmet CPAP. This is a prospective pilot study to (1) determine if infants and pediatric patients requiring CPAP in the PICU will tolerate helmet CPAP for at least four hours, and (2) measure changes in the respiratory rate, oxygen saturation, heart rate and blood pressure over four hours. If helmet CPAP is found to be well tolerated in this small cohort, a larger study comparing it directly to other CPAP interfaces will be conducted.

02

Conditions studied

  • Bronchiolitis, Viral
  • Pneumonia, Viral
  • Pneumonia, Bacterial
03

Who can participate

Ages eligible
1 Month to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • One month to 5 years of age (inclusive) admitted to the PICU with community acquired pneumonia or bronchiolitis, having been stable on nasal or facemask CPAP for at least four hours but less than 48 hours, and parental informed consent.

Exclusion criteria

Exclusion Criteria:

  • Age less than 1 month or greater than 5 years
  • Positive for COVID-19
  • Need for invasive mechanical ventilation or higher levels of non-invasive ventilation such as bi-level positive airway pressure (BPAP)
  • Unresponsiveness (GCS 8 or less)
  • Hypotension as defined as a systolic blood pressure less than 5th percentile for age
  • Existing head or neck trauma, known or suspected air leak syndrome (pneumothorax, pneumomediastinum, subcutaneous emphysema), known or suspected increased intracranial pressure
  • Non-English speaking parent
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Helmet CPAP

    Patients in the Pediatric Intensive Care Unit (PICU) already receiving CPAP through a facemask or nasal prongs or mask for at least four hours but no more than 48 hours will be transitioned to the Vyatil nonpowered oxygen tent system (Rochester, NY) by trained respiratory therapists per the manufacture's instructions: patient's neck circumference will be measured with a soft tape measure to ensure appropriate sizing. The helmet will be connected to at least 30 liters per minute of high flow medical air with an oxygen blender. The expiratory limb will be attached to the positive end expiratory pressure (PEEP) valve (initially set at 5 centimeters of water pressure) connected to a high-efficiency particulate air (HEPA) filter to prevent any viral particles from being released into the environment. A disposable manometer will be used to measure the pressure within the helmet. Once the flow to the helmet interface is on, the helmet will be sealed and secured with the system's arm straps.

    Device: Helmet CPAP

Interventions

  • DeviceHelmet CPAP

    Vyatil nonpowered oxygen tent system

05

What researchers measure

Primary outcomes

  1. Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours

    Tolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

    Time frame: Four hours

Secondary outcomes

  1. Respiratory Rate

    Respiratory rate will be measured in breaths per minute every hour for four hours.

    Time frame: 4 hours

  2. Heart Rate

    Heart rate will be measured in beats per minute every hour for 4 hours.

    Time frame: 4 hours

  3. Oxygen Saturation

    Pulse oxygen saturation will be measured as a percent every hour for 4 hours.

    Time frame: 4 hours

  4. Systolic Blood Pressure

    Systolic blood pressure will be measured in millimeters of mercury every hour for 4 hours.

    Time frame: 4 hours

06

Results

Posted Jul 29, 2024

Participant flow

Participant flow — Overall Study
MilestoneHelmet CPAP
Started5
Completed5
Not completed0

Outcome measures

PrimaryNumber of Participants Who Tolerated CPAP Helmet for at Least Four Hours

Tolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

Time frame:
Four hours
Reported as:
Count of participants · Participants
Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours
ParticipantsHelmet CPAP
Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours5
SecondaryRespiratory Rate

Respiratory rate will be measured in breaths per minute every hour for four hours.

Time frame:
4 hours

No measurements were reported for this outcome.

SecondaryHeart Rate

Heart rate will be measured in beats per minute every hour for 4 hours.

Time frame:
4 hours

No measurements were reported for this outcome.

SecondaryOxygen Saturation

Pulse oxygen saturation will be measured as a percent every hour for 4 hours.

Time frame:
4 hours

No measurements were reported for this outcome.

SecondarySystolic Blood Pressure

Systolic blood pressure will be measured in millimeters of mercury every hour for 4 hours.

Time frame:
4 hours

No measurements were reported for this outcome.

Adverse events

Collected over Up to 4 hours. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Helmet CPAP0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Helmet CPAP
<=18 years5
Between 18 and 65 years0
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Helmet CPAP
Female3
Male2
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Helmet CPAP
Hispanic or Latino3
Not Hispanic or Latino2
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Helmet CPAP
American Indian or Alaska Native0
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American1
White0
More than one race0
Unknown or Not Reported3
Region of Enrollment
Region of Enrollment(Participants)Helmet CPAP
United States5
Admission Diagnosis
Admission Diagnosis(Participants)Helmet CPAP
Viral Bronchiolitis3
Viral Pneumonia2
07

Study locations

1 site
  • Columbia University Medical Center
    New York, New York 10032, United States
08

References and documents

Study documents

  • Study protocol · Aug 23, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Pilot study

09

Registry details

Key details

Study ID
NCT04764929
Lead sponsor
Columbia University
Responsible party
Sponsor
First posted
Feb 21, 2021
Start date
Aug 7, 2021
Primary completion
May 19, 2022
Completion
Jun 14, 2023
Results posted
Jul 29, 2024
Last update
Jul 29, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion